MSH3 and exocrine pancreatic carcinoma: The TCGA data [34] indicate that MSH3 mutations, deep deletion or low mRNA expression are not frequent enough to explain the generation of all the observed EMAST in non-MSI-H colorectal or pancreatic carcinomas.